Using immunotherapy and radiation to treat HPV-related throat cancer
Neoadjuvant immunoradiotherapy for HPV mediated oropharynx cancer
This study is looking at a new way to treat throat cancer caused by HPV by combining special medicines that help your immune system with targeted radiation, aiming to improve how well patients respond to treatment while protecting healthy tissues.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-10930922 on NIH RePORTER |
What this research studies
This research investigates a new treatment approach for HPV-mediated oropharynx cancer, which is expected to rise in incidence. The study aims to combine PD-1 inhibitors with targeted radiation therapy to improve patient outcomes. By focusing on sparing lymphatic tissues while treating the tumor, the researchers hope to enhance the immune response against the cancer. This innovative strategy is based on previous findings that suggest the importance of lymphatic health in mounting an effective immune response.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with locally advanced HPV-mediated oropharynx cancer who have not yet received treatment.
Not a fit: Patients with recurrent or metastatic head and neck squamous cell carcinoma who have already undergone treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and less harmful treatment options for patients with HPV-related throat cancer.
How similar studies have performed: While PD-1 inhibitors have shown limited success in untreated HPV-related cancers, this approach of combining immunotherapy with targeted radiation is novel and has not been extensively tested.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Califano, Joseph a — University of California, San Diego
- Study coordinator: Califano, Joseph a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.